NEW YORK, NY / ACCESSWIRE / April 24, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Diplomat Pharmacy, Inc. (DPLO)
Class Period: February 26, 2018 - February 21, 2019
Lead Plaintiff Deadline : April 25, 2019
Join the action: https://www.zlk.com/pslra-1/diplomat-pharmacy-inc-loss-form?prid=1260&wire=1
About the lawsuit: Diplomat Pharmacy, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants' statements about Diplomat's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Diplomat Pharmacy, Inc. class action contact email@example.com.
Healthcare Services Group, Inc. (HCSG)
Class Period: April 11, 2017 - March 4, 2019
Lead Plaintiff Deadline : May 21, 2019
Join the action: https://www.zlk.com/pslra-1/healthcare-services-group-inc-loss-form?prid=1260&wire=1
About the lawsuit: During the class period, Healthcare Services Group, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Defendant Wahl either knew or was reckless in not knowing that the Company had been accused of strategically rounding quarterly earnings per share, and therefore investors could not rely upon the Company's track record without conducting a thorough investigation into the allegations; (b) Defendants concealed that the SEC had written to the Company in November 2017 to inquire into the Company's earnings per share rounding practices; and (c) the Company concealed that the SEC delivered a subpoena to the Company in March 2018 demanding the Company produce documents in connection with how it calculated earnings per share.
To learn more about the Healthcare Services Group, Inc. class action contact firstname.lastname@example.org.
The Boeing Company (BA)
Class Period: January 8, 2019 - March 21, 2019
Lead Plaintiff Deadline : June 10, 2019
Join the action: https://www.zlk.com/pslra-1/the-boeing-company-loss-form-2?prid=1260&wire=1
About the lawsuit: The Boeing Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Boeing's 737 MAX airplanes were not as safe as previous models, therefore Boeing included undisclosed ''hacks'' created by engineering compromises and the lack of safety features which Boeing sold as ''optional'' add-ons which were designed to help address these safety concerns; (2) most airlines did not purchase these safety ''options''; (3) the Federal Aviation Administration granted Boeing its own oversight and certification of Boeing’s new flight control system, or Maneuvering Characteristics Augmentation Systems, which was a clear conflict of interest as Boeing was rushing the 737 MAX airplanes to market; and (4) as a result of the foregoing, Boeing's public statement were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To learn more about the The Boeing Company class action contact email@example.com.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: